Advanced Search

Home > Journals > Minerva Medica > Past Issues > Articles online first > Minerva Medica 2016 Sep 14

ISSUES AND ARTICLES   MOST READ   eTOC

CURRENT ISSUEMINERVA MEDICA

A Journal on Internal Medicine

Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,236

Frequency: Bi-Monthly

ISSN 0026-4806

Online ISSN 1827-1669

 

Minerva Medica 2016 Sep 14

The role of endoscopic ultrasound in the management of intraductal papillary mucinous neoplasms: a systematic update

Lyn A. SMITH, Colin J. MCKAY

West of Scotland Pancreatic Unit, Glasgow Royal Infirmary, Glasgow, Scotland

The widespread use of cross-sectional imaging has lead to an increased frequency of incidentally detected pancreatic cysts. Neoplastic cysts such as mucinous lesions and solid pseudopapillary neoplasms have malignant potential and therefore the early detection of these lesions presents an opportunity for prevention or early detection and management of pancreatic adenocarcinoma. Serous neoplastic lesions and non-neoplastic pancreatic cysts such as pseudocysts or walled off pancreatic necrosis and are not associated with malignant potential. It is important to identify those mucinous lesions with the highest potential of malignancy in order to direct management either towards surveillance or resection. The preoperative diagnosis of these cysts is a challenge as cross-sectional imaging alone is often inadequate at making the diagnosis. Endoscopic ultrasound (EUS) with or without fine needle aspiration (FNA) can assess the morphology of cysts including identification of high risk characteristics of cysts as well as allowing aspiration of cyst fluid, which can be analysed for cytology, mucin, tumour markers, amylase and molecular markers. Intraductal papillary mucinous neoplasms (IPMN) have three main subtypes; main duct IPMNs (MD-IPMN), branch duct IPMNs (BD-IPMN) and mixed type IPMNs which have feature of both the aforementioned. MD-IPMNs have the highest malignant potential and are often easier to identify on cross-sectional imaging due to the involvement of the main pancreatic duct. Current guidelines suggest that these lesions should generally be considered for resection without further evaluation. Several guidelines exist for the investigation and management of BD-IPMNs, which have a lower malignant potential and there has been much interest in more clearly defining the role of EUS and EUS-FNA in this group of patients. In this review article we discuss the role of EUS in the diagnosis, risk stratification and management of these lesions.

language: English


FULL TEXT  REPRINTS

top of page